Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

2(40.0%)

Phase 2

1(20.0%)

Phase 3

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(2)

Phase 2(1)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT04011800Phase 3Unknown

PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification.

Role: collaborator

NCT02360137Active Not Recruiting

Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke

Role: collaborator

NCT05743322Not ApplicableUnknown

The Usefulness of Biatrial 3D Printing to Plan Transseptal Puncture for the Left Atrial Appendage Closure

Role: collaborator

NCT03047538Phase 4Withdrawn

Fixed Combination for Lipid and Blood Pressure Control

Role: collaborator

NCT01310101Phase 2Completed

Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia

Role: collaborator

NCT01550640Not ApplicableCompleted

Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia

Role: collaborator

All 6 trials loaded